Teva Pharmaceutical Industries Limited (LON:0LER)

London flag London · Delayed Price · Currency is GBP · Price in USD
33.82
+0.48 (1.43%)
At close: Jan 30, 2026
81.03%
Market Cap28.50B +40.1%
Revenue (ttm)12.82B +4.3%
Net Income1.05B
EPS0.90
Shares Outn/a
PE Ratio27.20
Forward PE12.44
Dividendn/a
Ex-Dividend Daten/a
Volume15,665
Average Volume11,308
Open33.00
Previous Close33.34
Day's Range32.38 - 33.92
52-Week Range12.50 - 34.62
Beta0.66
RSI74.22
Earnings DateJan 28, 2026

About LON:0LER

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com... [Read more]

Industry Pharmaceutical Preparations
Founded 1901
Employees 37,000
Stock Exchange London Stock Exchange
Ticker Symbol 0LER
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements